These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25102791)

  • 41. Pain Hypersensitivity in SLURP1 and SLURP2 Knock-out Mouse Models of Hereditary Palmoplantar Keratoderma.
    Weinberg RL; Kim S; Pang Z; Awad S; Hanback T; Pan B; Bettin L; Chang D; Polydefkis MJ; Qu L; Caterina MJ
    J Neurosci; 2024 Jul; 44(28):. PubMed ID: 38866482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Japanese case of Mal de Meleda with SLURP1 mutation.
    Sakabe J; Kabashima-Kubo R; Kubo A; Sasaki T; Tokura Y
    J Dermatol; 2014 Aug; 41(8):764-5. PubMed ID: 24985918
    [No Abstract]   [Full Text] [Related]  

  • 43. Haplotype analysis in western European patients with mal de Meleda: founder effect for the W15R mutation in the SLURP1 gene.
    Nellen RG; Steijlen PM; Hennies HC; Fischer J; Munro CS; Jonkman MF; van Steensel MA; van Geel M
    Br J Dermatol; 2013 Jun; 168(6):1372-4. PubMed ID: 23290002
    [No Abstract]   [Full Text] [Related]  

  • 44.
    Jafar Hussain HM; Khan R; Li C; Aftab A; Muneer I; Wahab F; Wu L; Jiang X; Xu P
    Ann Clin Lab Sci; 2019 Nov; 49(6):710-721. PubMed ID: 31882421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterogeneity in the properties of mutant secreted lymphocyte antigen 6/urokinase receptor-related protein 1 (SLURP1) in Mal de Meleda.
    Adeyo O; Oberer M; Ploug M; Fong LG; Young SG; Beigneux AP
    Br J Dermatol; 2015 Oct; 173(4):1066-9. PubMed ID: 25919322
    [No Abstract]   [Full Text] [Related]  

  • 46. A novel homozygous missense mutation in SLURP1 causing Mal de Meleda with an atypical phenotype.
    Gruber R; Hennies HC; Romani N; Schmuth M
    Arch Dermatol; 2011 Jun; 147(6):748-50. PubMed ID: 21690549
    [No Abstract]   [Full Text] [Related]  

  • 47. Gene Symbol: ars. Disease: Mal de Meleda.
    Abdelhak S; Charfeddine C; Mokni M; Mousli RB; Elkares R; Bouchlaka C; Boubaker S; Ghedamsi S; Baccouche D; Osman AB; Dellagi K
    Hum Genet; 2004 May; 114(6):609. PubMed ID: 15176391
    [No Abstract]   [Full Text] [Related]  

  • 48. [Meleda disease (mal de Meleda). Data and considerations on an indigenous caseload].
    Salamon T; Berberovic L; Topic B; Basic V
    G Ital Dermatol Venereol; 1988 Dec; 123(12):649-55. PubMed ID: 2978158
    [No Abstract]   [Full Text] [Related]  

  • 49. Electron microscopic study of fingernails in the disease of Mljet (Mal de Meleda).
    Salamon T; Plavsić B; Nikulin A
    Acta Derm Venereol; 1984; 64(4):302-7. PubMed ID: 6209887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hairgrowth over the thenar and the sole in Mal de Meleda (Mljet disease).
    Salamon T
    Acta Derm Venereol; 1985; 65(4):352-3. PubMed ID: 2413696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda.
    Chimienti F; Hogg RC; Plantard L; Lehmann C; Brakch N; Fischer J; Huber M; Bertrand D; Hohl D
    Hum Mol Genet; 2003 Nov; 12(22):3017-24. PubMed ID: 14506129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Compound heterozygosity for ARS component B mutations in a Dutch patient with mal de Meleda.
    Nellen RG; van Geel M; Steijlen PM; van Steensel MA
    Br J Dermatol; 2009 Apr; 160(4):878-80. PubMed ID: 19120323
    [No Abstract]   [Full Text] [Related]  

  • 53. Biochemical Basis of Skin Disease Mal de Meleda: SLURP-1 Mutants Differently Affect Keratinocyte Proliferation and Apoptosis.
    Shulepko MA; Bychkov ML; Shenkarev ZO; Kulbatskii DS; Makhonin AM; Paramonov AS; Chugunov AO; Kirpichnikov MP; Lyukmanova EN
    J Invest Dermatol; 2021 Sep; 141(9):2229-2237. PubMed ID: 33741389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A brief history of dermatovenereology in Dubrovnik.
    Bakija-Konsuo A; Marlais M
    Acta Dermatovenerol Croat; 2012; 20(3):141-7. PubMed ID: 23069298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pseudodominant inheritance with the G86R mutation in the ARS gene in Mal de Meleda.
    Chao SC; Huang CY; Lai FJ; Yang MH
    Int J Dermatol; 2006 Dec; 45(12):1456-8. PubMed ID: 17184264
    [No Abstract]   [Full Text] [Related]  

  • 56. Particular Mal de Meleda phenotypes in Tunisia and mutations founder effect in the Mediterranean region.
    Bchetnia M; Laroussi N; Youssef M; Charfeddine C; Ben Brick AS; Boubaker MS; Mokni M; Abdelhak S; Zili J; Benmously R
    Biomed Res Int; 2013; 2013():206803. PubMed ID: 24093092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel mutation in the ARS (component B) gene encoding SLURP-1 in a Turkish family with mal de Meleda.
    Muslumanoglu MH; Saracoglu N; Cilingir O; Basmaci T; Urer S; Sabuncu I; Demir S; Bademci G; Artan S
    Br J Dermatol; 2006 Aug; 155(2):467-9. PubMed ID: 16882192
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevalence of dermatomycoses in Mal de Meleda patients: a field study.
    Ergin C; Ergin S; Arikan S
    Scand J Infect Dis; 2002; 34(10):753-5. PubMed ID: 12477326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and genetic studies of 3 large, consanguineous, Algerian families with Mal de Meleda.
    Bouadjar B; Benmazouzia S; Prud'homme JF; Cure S; Fischer J
    Arch Dermatol; 2000 Oct; 136(10):1247-52. PubMed ID: 11030771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 200th anniversary (1804-2004) of the publication of the poem: Vaccinatio; De Jenneriano invento optime merito; Carmen elegiacum; by Croatian scientist Luko Stulli.
    Borovecki A; Pavlović C
    Croat Med J; 2004 Oct; 45(5):655-73. PubMed ID: 15495297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.